ALMKT:EPA
Mauna Kea Technologies SA
€0.094
arrow_downward
-1.26%(-0.0012) 1D
Nov 12, 2:19:14 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALMKT...
Open
€0.10
High
€0.10
Low
€0.09
Mkt. cap
19.29M
Avg. vol.
545.11K
Volume
173.18K
P/E ratio
0.80
52-wk high
€0.23
52-wk low
€0.07
EPS
€0.12
Shares outstanding
195.26M
No. of employees
56
Open
€0.10
High
€0.10
Low
€0.09
Mkt. cap
19.29M
Avg. vol.
545.11K
Volume
173.18K
P/E ratio
0.80
52-wk high
€0.23
52-wk low
€0.07
EPS
€0.12
Shares outstanding
195.26M
No. of employees
56
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
Dow Advances Texas Advanced Nuclear Project With NRC Approval
Invezz
·
1 hour ago
VOO & Chill is gaining momentum: What comes next for the S&P 500?
www.tmgm.com
·
2 hours ago
Dow Jones futures remain steady amid hawkish Fed rate outlook, Nvidia leadership turmoil
Profile
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
About Mauna Kea Technologies SA
CEOSacha Loiseau
Employees56
Founded2000
Headquarters-
SectorHealth Care
IndustryMedical device
Websitemaunakeatech.com